V

Veru
D

VERU

0.66830
USD
0.03
(4.02%)
Market Open
Volume
12,645
EPS
-0
Div Yield
-
P/E
-2
Market Cap
97,828,374
OverviewSignalsIdeasNews
Related Instruments
    A
    ACOR
    -0.26810
    (-30.48%)
    0.61160 USD
    A
    AGEN
    -0.07000
    (-2.47%)
    2.76000 USD
    A
    ALRN
    0.04000
    (2.29%)
    1.79000 USD
    C
    CTMX
    0.00000
    (0.00%)
    1.09000 USD
    E
    ESPR
    0.03500
    (1.61%)
    2.21500 USD
    L
    LPCN
    -0.17000
    (-3.50%)
    4.69000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VKTX
    -0.800
    (-1.89%)
    41.470 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: Veru

Sector: Healthcare
Industry: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.